The effect of the ATG16L1 Thr300Ala polymorphism on susceptibility and outcome of patients with epithelial cell-derived thyroid carcinoma

Endocrine-Related Cancer

Volumn 19, Issue 3, 2012, Pages

  Huijbers, Angelique ^a   Plantinga, Theo S ^a   Joosten, Leo A B ^a   Aben, Katja K H ^a,b   Gudmundsson, Julius ^c   Den Heijer, Martin ^a   Kiemeney, Lambertus A L M ^a,b   Netea, Mihai G ^a   Hermus, Ad R M M ^a   Netea Maier, Romana T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Oost   (Netherlands)

^c DECODE GENETICS   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; INTERLEUKIN 1BETA; IODINE 131; THREONINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ALLELE; ATG16L1 GENE; AUTOPHAGOSOME; AUTOPHAGY; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GENE; GENE DOSAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFLAMMATION; LETTER; LYMPH NODE METASTASIS; NECK DISSECTION; PATHOPHYSIOLOGY; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; CARRIER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84862662855     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0302     Document Type: Letter

References (10)

1. Apte RN & Voronov E 2002 Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions. Seminars in Cancer Biology 12 277-290. (doi:10.1016/S1044-579X(02)00014-7)
2. Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D & Simmons A 2010 NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nature Medicine 16 90-97. (doi:10.1038/nm.2069)
3. Duntas LH & Doumas C 2009 The 'rings of fire' and thyroid cancer. Hormones 8 249-253.
4. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir1 M et al. 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nature Genetics 41 460-464. (doi:10.1038/ng.339)
5. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL et al. 2009 International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes & Control 20 525-531. (doi:10.1007/s10552-008-9260-4)
6. Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, Izumi M & Nagataki S 1992 Interleukin-1 inhibits human thyroid carcinoma cell growth. Journal of Clinical Endocrinology and Metabolism 75 596-602. (doi:10.1210/jc.75.2.596)
7. Netea-Maier RT, Aben KK, Casparie MK, den Heijer M, Grefte JM, Slootweg P & Hermus A 2008 Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. International Journal of Cancer 123 1681-1684. (doi:10.1002/ijc.23678)
8. Ohta K, Pang XP, Berg L & Hershman JM 1996 Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. Journal of Clinical Endocrinology and Metabolism 81 2607-2612. (doi:10.1210/jc.81.7.2607)
9. Plantinga TS, Crisan TO, Oosting M, van de Veerdonk FL, de Jong DJ, Philpott DJ, van der Meer JW, Girardin SE, Joosten LA & Netea MG 2011 Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut 60 1229-1235. (doi:10.1136/gut.2010.228908)
10. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M et al. 2008 Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456 264-268. (doi:10.1038/nature07383)